Differential lineage-specific regulation of murine CD45 transcription by Oct-1 and PU.1

Biochemical and Biophysical Research Communications

Volumn 344, Issue 1, 2006, Pages 146-154

  Kwon, Un ^a,b   Yen, Pei Hua ^a,b   Collins, Tara ^a,b   Wells, Richard A ^a,b  

^a Sunnybrook Health Sciences Centre   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Alternative start site; CD45; Oct 1; Oct 2; Octamer; PTPRC; PU.1; Transcription factor; Transcriptional regulation

Indexed keywords

CD45 ANTIGEN; MESSENGER RNA; MITOGENIC AGENT; OCTAMER TRANSCRIPTION FACTOR 1; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR PU 1;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; CONTROLLED STUDY; HEMATOPOIETIC CELL; LYMPHOID CELL LINE; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

5' FLANKING REGION; ANIMALS; ANTIGENS, CD45; BASE SEQUENCE; BINDING SITES; CELL LINEAGE; GENE EXPRESSION REGULATION; LYMPHOCYTES; MICE; MOLECULAR SEQUENCE DATA; MYELOID CELLS; OCTAMER TRANSCRIPTION FACTOR-1; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC;

ANIMALIA; MURINAE;

EID: 33646061033     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.119     Document Type: Article

References (33)

1. Johnson N.A., Meyer C.M., Pingel J.T., and Thomas M.L. Sequence conservation in potential regulatory regions of the mouse and human leukocyte common antigen gene. J. Biol. Chem. 264 (1989) 6220-6229
2. Trowbridge I.S., and Thomas M.L. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12 (1994) 85-116
3. Saga Y., Tung J.S., Shen F.W., and Boyse E.A. Sequences of Ly-5 cDNA: isoform-related diversity of Ly-5 mRNA [published erratum appears in Proc. Natl. Acad. Sci. USA 84 (7) (1987) 1991]. Proc. Natl. Acad. Sci. USA 83 (1986) 6940-6944
4. Raschke W.C. Cloned murine T200 (Ly-5) cDNA reveals multiple transcripts within B- and T-lymphocyte lineages. Proc. Natl. Acad. Sci. USA 84 (1987) 161-165
5. Streuli M., Hall L.R., Saga Y., Schlossman S.F., and Saito H. Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J. Exp. Med. 166 (1987) 1548-1566
6. Kishihara K., Penninger J., Wallace V.A., Kundig T.M., Kawai K., Wakeham A., Timms E., Pfeffer K., Ohashi P.S., Thomas M.L., et al. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 74 (1993) 143-156
7. Roach T., Slater S., Koval M., White L., McFarland E.C., Okumura M., Thomas M., and Brown E. CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion. Curr. Biol. 7 (1997) 408-417
8. Irie-Sasaki J., Sasaki T., Matsumoto W., Opavsky A., Cheng M., Welstead G., Griffiths E., Krawczyk C., Richardson C.D., Aitken K., Iscove N., Koretzky G., Johnson P., Liu P., Rothstein D.M., and Penninger J.M. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 409 (2001) 349-354
9. Ratei R., Sperling C., Karawajew L., Schott G., Schrappe M., Harbott J., Riehm H., and Ludwig W.D. Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia. Ann. Hematol. 77 (1998) 107-114
10. Jaffredo T., Gautier R., Eichmann A., and Dieterlen-Lievre F. Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny. Development 125 (1998) 4575-4583
11. Taetle R., Ostergaard H., Smedsrud M., and Trowbridge I. Regulation of CD45 expression in human leukemia cells. Leukemia 5 (1991) 309-314
12. Saga Y., Tung J.S., Shen F.W., Pancoast T.C., and Boyse E.A. Organization of the Ly-5 gene. Mol. Cell. Biol. 8 (1988) 4889-4895
13. Anderson K.L., Nelson S.L., Perkin H.B., Smith K.A., Klemsz M.J., and Torbett B.E. PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45. J. Biol. Chem. 276 (2001) 7637-7642
14. DiMartino J.F., Hayes P., Saga Y., and Lee J.S. A novel initiator/promoter element within the CD45 upstream region. Int. Immunol. 6 (1994) 1279-1283
15. Virts E.L., and Raschke W.C. The role of intron sequences in high level expression from CD45 cDNA constructs. J. Biol. Chem. 276 (2001) 19913-19920
16. Sukhai M.A., Wu X., Xuan Y., Zhang T., Reis P.P., Dube K., Rego E.M., Bhaumik M., Bailey D.J., Wells R.A., Kamel-Reid S., and Pandolfi P.P. Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RARalpha. Oncogene 23 (2004) 665-678
17. Ralph P., and Nakoinz I. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS. J. Immunol. 119 (1977) 950-954
18. Ma X., Chow J.M., Gri G., Carra G., Gerosa F., Wolf S.F., Dzialo R., and Trinchieri G. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183 (1996) 147-157
19. Vyas P., McDevitt M.A., Cantor A.B., Katz S.G., Fujiwara Y., and Orkin S.H. Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene. Development 126 (1999) 2799-2811
20. Ullman K.S., Flanagan W.M., Edwards C.A., and Crabtree G.R. Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40. Science 254 (1991) 558-562
21. Wu G.D., Lai E.J., Huang N., and Wen X. Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter. The role of Oct-1 as a transcriptional repressor. J. Biol. Chem. 272 (1997) 2396-2403
22. Kaushansky K., Shoemaker S.G., O'Rork C.A., and McCarty J.M. Coordinate regulation of multiple human lymphokine genes by Oct-1 and potentially novel 45 and 43 kDa polypeptides. J. Immunol. 152 (1994) 1812-1820
23. Malone C.S., Patrone L., and Wall R. An essential octamer motif in the mb-1 (Igalpha) promoter. Mol. Immunol. 37 (2000) 321-328
24. Malone C.S., Patrone L., Buchanan K.L., Webb C.F., and Wall R. An upstream Oct-1- and Oct-2-binding silencer governs B29 (Ig beta) gene expression. J. Immunol. 164 (2000) 2550-2556
25. Tovar V., de la Fuente M.A., Pizcueta P., Bosch J., and Engel P. Gene structure of the mouse leukocyte cell surface molecule Ly9. Immunogenetics 51 (2000) 788-793
26. Shah P.C., Bertolino E., and Singh H. Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription. EMBO J. 16 (1997) 7105-7117
27. Konig H., Pfisterer P., Corcoran L.M., and Wirth T. Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2. Genes Dev. 9 (1995) 1598-1607
28. Pfisterer P., Konig H., Hess J., Lipowsky G., Haendler B., Schleuning W.D., and Wirth T. CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2. Mol. Cell. Biol. 16 (1996) 6160-6168
29. Chen H., Zhang P., Radomska H.S., Hetherington C.J., Zhang D.E., and Tenen D.G. Octamer binding factors and their coactivator can activate the murine PU.1 (spi-1) promoter. J. Biol. Chem. 271 (1996) 15743-15752
30. Sjoblom A., Jansson A., Yang W., Lain S., Nilsson T., and Rymo L. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter. J. Gen. Virol. 76 Pt. 11 (1995) 2679-2692
31. Kistler B., Pfisterer P., and Wirth T. Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors. Oncogene 11 (1995) 1095-1106
32. Schwarzenbach H., Newell J.W., and Matthias P. Involvement of the Ets family factor PU.1 in the activation of immunoglobulin promoters. J. Biol. Chem. 270 (1995) 898-907
33. Kamps M.P., Corcoran L., LeBowitz J.H., and Baltimore D. The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. Mol. Cell. Biol. 10 (1990) 5464-5472